+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Conjunctivitis Drug"

From
From
Viral Conjunctivitis - Pipeline Review, H2 2020 - Product Thumbnail Image

Viral Conjunctivitis - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 52 Pages
  • Global
From
Rhino-Conjunctivitis - Pipeline Review, H2 2019 - Product Thumbnail Image

Rhino-Conjunctivitis - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 74 Pages
  • Global
From
From
Loading Indicator

The Conjunctivitis Drug market is a subset of the Optical Disorders Drugs market, which includes drugs used to treat a variety of eye conditions. Conjunctivitis is an inflammation of the conjunctiva, the thin, transparent membrane that lines the inner surface of the eyelids and covers the white part of the eye. Conjunctivitis drugs are used to treat the symptoms of the condition, such as redness, itching, and discharge. These drugs can be administered topically, orally, or intravenously, depending on the severity of the condition. Commonly prescribed drugs for conjunctivitis include antibiotics, antihistamines, and corticosteroids. The Conjunctivitis Drug market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Allergan, Bausch + Lomb, Merck, Novartis, Pfizer, and Santen Pharmaceuticals. Show Less Read more